Industry reports
Editor highlights

Biological Therapy Industry in Spain: Market Research Reports, Statistics and Analysis

You might be interested in: cell therapy, stem cell, cell culture, more »

» View Public Reports

7 reports

Cytokine Sector in Spain

  • Industry report
  • October 2011
  • 9 pages

... cytokines was proposed as a strategy for early detection of immunotoxicity (pallardy et al., 1998). Studies in rats have shown that administration with mdma increases the secretion of th1-type cytokine il-2 ...

Cell Therapy Industry in Portugal and Spain

  • Industry report
  • June 2011
  • 33 pages

... cell lines, zebrafish embryo, toxicogenomic) to study the bioavailability and risk assessment of pahs and heavy metals in processed food products, using smoked meat sausage and cooked edible crab ...

Company Report: Cell Therapy in Europe for Year 2013

  • Company report
  • March 2013
  • 7 pages

... Track record that will be of immense value as tigenix enters into a pivotal phase of its growth with the commercial roll-out of chondrocelect and the advanced clinical development of its cell therapy ...

Company Report: Cell Therapy in Europe for Year 2012

  • Company report
  • March 2012
  • 4 pages

... Reimbursement was approved in march. Chondrocelect is the first ema approved and reimbursed cell therapy product in europe. It is indicated for the repair of single symptomatic cartilage defects ...

Cryo-Save Group N.V. - Annual Report 2012

  • Company report
  • March 2012
  • 20 pages

... Reconfirms that cryo-save is active in a market that holds a strong future promise as the conditions treatable with stem cells as well as clinical trial activities are increasing continuously ...

Company Report: Biological Therapy in Europe for Year 2011

  • Company report
  • March 2011
  • 22 pages
  • by Corporation
Search in Biological Therapy Industry

» Purchase Premium Reports (From $ 750 - $ 15 200)

7 reports
TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary TiGenix NV (TiGenix) is a biomedical cell therapy company. The company specializes in the development of innovative local treatments for damaged and diseased tissues. It mainly focuses on the therapeutic ...

Market And Product Forecasts: Targeted Cancer Therapies ...

July 2012 $ 11 400

Analysis Of The Stem Cell Markets-unlocking The New Era ...

January 2012 $ 6 000

Oncology Devices Market To 2017 - Improved Efficiency, ...

December 2011 $ 3 500

Market And Product Projections : Targeted Cancer Therap ...

October 2011 $ 11 400

The Stem Cell Market Outlook

June 2011 $ 3 835

Biological Therapy In Japan: Commercial Insight: Top 20 ...

September 2010 $ 15 200

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.